z-logo
open-access-imgOpen Access
Is polycystic kidney disease associated with malignancy in children?
Author(s) -
Friend Brian D.,
Wolfe Schneider Kami,
Garrington Timothy,
Truscott Laurel,
MartinezAgosto Julian A.,
Venick Robert S.,
Tsai Chambers Eileen,
Weng Patricia,
Farmer Douglas G.,
Chang Vivian Y.,
Federman Noah
Publication year - 2019
Publication title -
molecular genetics and genomic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.765
H-Index - 29
ISSN - 2324-9269
DOI - 10.1002/mgg3.725
Subject(s) - medicine , malignancy , polycystic kidney disease , disease , kidney disease , kidney , cystic kidney disease , autosomal recessive polycystic kidney disease , cancer , pathology , family history , pancreas , genetic predisposition
Background Polycystic kidney disease (PKD) is an inherited condition characterized by progressive development of end‐stage renal disease, hypertension, hepatic fibrosis, and cysts in the kidney, liver, pancreas, spleen, thyroid, and epididymis. While malignancies have been reported in association with PKD in adults, the incidence of malignancies in children with PKD is not currently known. Methods We report on five patients with a known history of PKD who developed a malignancy as children at the University of California, Los Angeles and the University of Colorado Anschutz Medical Campus. Patients were included from 2012 to 2017. Results We present five patients with a history of PKD diagnosed with a malignancy during childhood without any additional known mutations to suggest a genetic predisposition to develop cancer. This includes the first reported case of hepatocellular carcinoma in a patient with autosomal recessive polycystic kidney disease. Conclusion Our report illustrates the potential that PKD may be associated with an increased risk for developing cancer, even in children. Further research is necessary to better understand this relationship.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here